United States Neurological Biomarkers Market by Manufacturers, States, Type and Application, Forecast to 2022

May 2018 | 115 pages | ID: U1B59E594B3EN
GlobalInfoResearch

Abstracts

A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus. In the era of molecular medicine, biomarkers usually mean molecular biomarkers and can be divided into 3 broad categories

Scope of the Report:

This report focuses on the Neurological Biomarkers in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers

• Thermo Fisher
• Merck
• Bio-Rad Laboratories
• Roche
• QIAGEN
• Athena Diagnostics
• Myriad RBM
• Cisbio Bioassays
• Wuxi APP
• BGI
• Aepodia
• Genewiz
• Proteome Sciences

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Market Segment by Type, covers

• Proteomics
• Genomics
• Imaging
• Bioinformatics
• Others

Market Segment by Applications, can be divided into

• Diagnostics
• Drug Discovery
• Personalized Medicine
• Others

There are 17 Chapters to deeply display the United States Neurological Biomarkers market.

Chapter 1, to describe Neurological Biomarkers Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Neurological Biomarkers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Neurological Biomarkers, for each state, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;

Chapter 12, Neurological Biomarkers market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 15, to describe sales channel, distributors, traders, dealers etc.

Chapter 16 and 17, to describe Neurological Biomarkers Research Findings and Conclusion, Appendix, methodology and data source.

Contents

1 MARKET OVERVIEW

1.1 Neurological Biomarkers Introduction
1.2 Market Analysis by Type
  1.2.1 Proteomics
  1.2.2 Genomics
  1.2.3 Imaging
  1.2.4 Bioinformatics
  1.2.5 Others
1.3 Market Analysis by Applications
  1.3.1 Diagnostics
  1.3.2 Drug Discovery
  1.3.3 Personalized Medicine
  1.3.4 Others
1.4 Market Analysis by States
  1.4.1 California Status and Prospect (2012-2022)
  1.4.2 Texas Status and Prospect (2012-2022)
  1.4.3 New York Status and Prospect (2012-2022)
  1.4.4 Florida Status and Prospect (2012-2022)
  1.4.5 Illinois Status and Prospect (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Thermo Fisher
  2.1.1 Profile
  2.1.2 Neurological Biomarkers Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Thermo Fisher Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.1.4 Business Overview
  2.1.5 Thermo Fisher News
2.2 Merck
  2.2.1 Profile
  2.2.2 Neurological Biomarkers Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Merck Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.2.4 Business Overview
  2.2.5 Merck News
2.3 Bio-Rad Laboratories
  2.3.1 Profile
  2.3.2 Neurological Biomarkers Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.3.4 Business Overview
  2.3.5 Bio-Rad Laboratories News
2.4 Roche
  2.4.1 Profile
  2.4.2 Neurological Biomarkers Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Roche Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.4.4 Business Overview
  2.4.5 Roche News
2.5 QIAGEN
  2.5.1 Profile
  2.5.2 Neurological Biomarkers Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 QIAGEN Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.5.4 Business Overview
  2.5.5 QIAGEN News
2.6 Athena Diagnostics
  2.6.1 Profile
  2.6.2 Neurological Biomarkers Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Athena Diagnostics Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.6.4 Business Overview
  2.6.5 Athena Diagnostics News
2.7 Myriad RBM
  2.7.1 Profile
  2.7.2 Neurological Biomarkers Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 Myriad RBM Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.7.4 Business Overview
  2.7.5 Myriad RBM News
2.8 Cisbio Bioassays
  2.8.1 Profile
  2.8.2 Neurological Biomarkers Type and Applications
    2.8.2.1 Type
    2.8.2.2 Type
  2.8.3 Cisbio Bioassays Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.8.4 Business Overview
  2.8.5 Cisbio Bioassays News
2.9 Wuxi APP
  2.9.1 Profile
  2.9.2 Neurological Biomarkers Type and Applications
    2.9.2.1 Type
    2.9.2.2 Type
  2.9.3 Wuxi APP Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.9.4 Business Overview
  2.9.5 Wuxi APP News
2.10 BGI
  2.10.1 Profile
  2.10.2 Neurological Biomarkers Type and Applications
    2.10.2.1 Type
    2.10.2.2 Type
  2.10.3 BGI Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.10.4 Business Overview
  2.10.5 BGI News
2.11 Aepodia
  2.11.1 Profile
  2.11.2 Neurological Biomarkers Type and Applications
    2.11.2.1 Type
    2.11.2.2 Type
  2.11.3 Aepodia Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.11.4 Business Overview
  2.11.5 Aepodia News
2.12 Genewiz
  2.12.1 Profile
  2.12.2 Neurological Biomarkers Type and Applications
    2.12.2.1 Type
    2.12.2.2 Type
  2.12.3 Genewiz Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.12.4 Business Overview
  2.12.5 Genewiz News
2.13 Proteome Sciences
  2.13.1 Profile
  2.13.2 Neurological Biomarkers Type and Applications
    2.13.2.1 Type
    2.13.2.2 Type
  2.13.3 Proteome Sciences Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.13.4 Business Overview
  2.13.5 Proteome Sciences News

3 UNITED STATES NEUROLOGICAL BIOMARKERS MARKET COMPETITION, BY MANUFACTURER

3.1 United States Neurological Biomarkers Sales and Market Share by Manufacturer (2016-2017)
3.2 United States Neurological Biomarkers Revenue and Market Share by Manufacturer (2016-2017)
3.3 United States Neurological Biomarkers Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Neurological Biomarkers Manufacturer Market Share
  3.4.2 Top 5 Neurological Biomarkers Manufacturer Market Share
3.5 Market Competition Trend

4 UNITED STATES NEUROLOGICAL BIOMARKERS MARKET ANALYSIS BY STATES

4.1 United States Neurological Biomarkers Sales Market Share by States
4.2 United States Neurological Biomarkers Sales by States (2012-2017)
4.3 United States Neurological Biomarkers Revenue (Value) by States (2012-2017)

5 UNITED STATES MARKET SEGMENTATION NEUROLOGICAL BIOMARKERS BY TYPE

5.1 United States Neurological Biomarkers Sales, Revenue and Market Share by Type (2012-2017)
  5.1.1 United States Neurological Biomarkers Sales and Market Share by Type (2012-2017)
  5.1.2 United States Neurological Biomarkers Revenue and Market Share by Type (2012-2017)
5.2 Proteomics Sales Growth and Price
  5.2.1 United States Proteomics Sales Growth (2012-2017)
  5.2.2 United States Proteomics Price (2012-2017)
5.3 Genomics Sales Growth and Price
  5.3.1 United States Genomics Sales Growth (2012-2017)
  5.3.2 United States Genomics Price (2012-2017)
5.4 Imaging Sales Growth and Price
  5.4.1 United States Imaging Sales Growth (2012-2017)
  5.4.2 United States Imaging Price (2012-2017)
5.5 Bioinformatics Sales Growth and Price
  5.5.1 United States Bioinformatics Sales Growth (2012-2017)
  5.5.2 United States Bioinformatics Price (2012-2017)
5.6 Others Sales Growth and Price
  5.6.1 United States Others Sales Growth (2012-2017)
  5.6.2 United States Others Price (2012-2017)

6 UNITED STATES MARKET SEGMENTATION NEUROLOGICAL BIOMARKERS BY APPLICATION

6.1 United States Neurological Biomarkers Sales Market Share by Application (2012-2017)
6.2 Diagnostics Sales Growth (2012-2017)
6.3 Drug Discovery Sales Growth (2012-2017)
6.4 Personalized Medicine Sales Growth (2012-2017)
6.5 Others Sales Growth (2012-2017)

7 CALIFORNIA NEUROLOGICAL BIOMARKERS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

7.1 California Neurological Biomarkers Revenue, Sales and Growth Rate (2012-2017)
7.2 California Neurological Biomarkers Sales and Market Share by Type
7.3 California Neurological Biomarkers Sales by Application (2012-2017)

8 NEW YORK NEUROLOGICAL BIOMARKERS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

8.1 New York Neurological Biomarkers Revenue, Sales and Growth Rate (2012-2017)
8.2 New York Neurological Biomarkers Sales and Market Share by Type
8.3 New York Neurological Biomarkers Sales by Application (2012-2017)

9 TEXAS NEUROLOGICAL BIOMARKERS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

9.1 Texas Neurological Biomarkers Revenue, Sales and Growth Rate (2012-2017)
9.2 Texas Neurological Biomarkers Sales and Market Share by Type
9.3 Texas Neurological Biomarkers Sales by Application (2012-2017)

10 FLORIDA NEUROLOGICAL BIOMARKERS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

10.1 Florida Neurological Biomarkers Revenue, Sales and Growth Rate (2012-2017)
10.2 Florida Neurological Biomarkers Sales and Market Share by Type
10.3 Florida Neurological Biomarkers Sales by Application (2012-2017)

11 ILLINOIS NEUROLOGICAL BIOMARKERS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

11.1 Illinois Neurological Biomarkers Revenue, Sales and Growth Rate (2012-2017)
11.2 Illinois Neurological Biomarkers Sales and Market Share by Type
11.3 Illinois Neurological Biomarkers Sales by Application (2012-2017)

12 NEUROLOGICAL BIOMARKERS MARKET FORECAST (2017-2022)

12.1 United States Neurological Biomarkers Sales, Revenue and Growth Rate (2017-2022)
12.2 Neurological Biomarkers Market Forecast by States (2017-2022)
12.3 Neurological Biomarkers Market Forecast by Type (2017-2022)
12.4 Neurological Biomarkers Market Forecast by Application (2017-2022)

13 NEUROLOGICAL BIOMARKERS MANUFACTURING COST ANALYSIS

13.1 Neurological Biomarkers Key Raw Materials Analysis
  13.1.1 Key Raw Materials
  13.1.2 Price Trend of Key Raw Materials
  13.1.3 Key Suppliers of Raw Materials
  13.1.4 Market Concentration Rate of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
  13.2.1 Raw Materials
  13.2.2 Labor Cost
  13.2.3 Manufacturing Expenses
13.3 Manufacturing Process Analysis of Neurological Biomarkers

14 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

14.1 Neurological Biomarkers Industrial Chain Analysis
14.2 Upstream Raw Materials Sourcing
14.3 Raw Materials Sources of Neurological Biomarkers Major Manufacturers in 2016
14.4 Downstream Buyers

15 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

15.1 Sales Channel
  15.1.1 Direct Marketing
  15.1.2 Indirect Marketing
  15.1.3 Marketing Channel Future Trend
15.2 Distributors, Traders and Dealers

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology
17.2 Analyst Introduction
17.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES


Figure Neurological Biomarkers Picture
Table Product Specifications of Neurological Biomarkers
Figure United States Sales Market Share of Neurological Biomarkers by Types in 2016
Table Types of Neurological Biomarkers
Figure Proteomics Picture
Table Major Manufacturers of Proteomics
Figure Genomics Picture
Table Major Manufacturers of Genomics
Figure Imaging Picture
Table Major Manufacturers of Imaging
Figure Bioinformatics Picture
Table Major Manufacturers of Bioinformatics
Figure Others Picture
Table Major Manufacturers of Others
Table United States Neurological Biomarkers Sales Market Share by Applications in 2016
Table Applications of Neurological Biomarkers
Figure Diagnostics Picture
Figure Drug Discovery Picture
Figure Personalized Medicine Picture
Figure Others Picture
Figure California Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure Texas Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure New York Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure Florida Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure Illinois Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Table Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table Thermo Fisher Neurological Biomarkers Type and Applications
Table Thermo Fisher Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Neurological Biomarkers Type and Applications
Table Merck Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table Bio-Rad Laboratories Neurological Biomarkers Type and Applications
Table Bio-Rad Laboratories Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Neurological Biomarkers Type and Applications
Table Roche Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table QIAGEN Basic Information, Manufacturing Base and Competitors
Table QIAGEN Neurological Biomarkers Type and Applications
Table QIAGEN Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Athena Diagnostics Basic Information, Manufacturing Base and Competitors
Table Athena Diagnostics Neurological Biomarkers Type and Applications
Table Athena Diagnostics Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Myriad RBM Basic Information, Manufacturing Base and Competitors
Table Myriad RBM Neurological Biomarkers Type and Applications
Table Myriad RBM Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cisbio Bioassays Basic Information, Manufacturing Base and Competitors
Table Cisbio Bioassays Neurological Biomarkers Type and Applications
Table Cisbio Bioassays Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Wuxi APP Basic Information, Manufacturing Base and Competitors
Table Wuxi APP Neurological Biomarkers Type and Applications
Table Wuxi APP Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BGI Basic Information, Manufacturing Base and Competitors
Table BGI Neurological Biomarkers Type and Applications
Table BGI Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Aepodia Basic Information, Manufacturing Base and Competitors
Table Aepodia Neurological Biomarkers Type and Applications
Table Aepodia Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Genewiz Basic Information, Manufacturing Base and Competitors
Table Genewiz Neurological Biomarkers Type and Applications
Table Genewiz Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Proteome Sciences Basic Information, Manufacturing Base and Competitors
Table Proteome Sciences Neurological Biomarkers Type and Applications
Table Proteome Sciences Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table United States Neurological Biomarkers Sales by Manufacturer (2016-2017)
Figure United States Neurological Biomarkers Sales Market Share by Manufacturer in 2016
Figure United States Neurological Biomarkers Sales Market Share by Manufacturer in 2017
Table United States Neurological Biomarkers Revenue by Manufacturer (2016-2017)
Figure United States Neurological Biomarkers Revenue Market Share by Manufacturer in 2015
Figure United States Neurological Biomarkers Revenue Market Share by Manufacturer in 2016
Table United States Neurological Biomarkers Price by Manufacturers (2016-2017)
Figure Top 3 Neurological Biomarkers Manufacturer Market Share in 2016
Figure Top 3 Neurological Biomarkers Manufacturer Market Share in 2017
Figure Top 5 Neurological Biomarkers Manufacturer Market Share in 2016
Figure Top 5 Neurological Biomarkers Manufacturer Market Share in 2017
Figure United States Neurological Biomarkers Sales and Growth (2012-2017)
Table United States Neurological Biomarkers Sales by States (2012-2017)
Table United States Neurological Biomarkers Sales Market Share by States (2012-2017)
Figure United States 2012 Neurological Biomarkers Sales Market Share by States
Figure United States 2016 Neurological Biomarkers Sales Market Share by States
Figure United States Neurological Biomarkers Revenue and Growth (2012-2017)
Table United States Neurological Biomarkers Revenue by States (2012-2017)
Table United States Neurological Biomarkers Revenue Market Share by States (2012-2017)
Table United States 2012 Neurological Biomarkers Revenue Market Share by States
Table United States 2016 Neurological Biomarkers Revenue Market Share by States
Table United States Neurological Biomarkers Sales by Type (2012-2017)
Table United States Neurological Biomarkers Sales Share by Type (2012-2017)
Table United States Neurological Biomarkers Revenue by Type (2012-2017)
Table United States Neurological Biomarkers Revenue Share by Type (2012-2017)
Figure United States Proteomics Sales Growth (2012-2017)
Figure United States Proteomics Price (2012-2017)
Figure United States Genomics Sales Growth (2012-2017)
Figure United States Genomics Price (2012-2017)
Figure United States Imaging Sales Growth (2012-2017)
Figure United States Imaging Price (2012-2017)
Figure United States Bioinformatics Sales Growth (2012-2017)
Figure United States Bioinformatics Price (2012-2017)
Figure United States Others Sales Growth (2012-2017)
Figure United States Others Price (2012-2017)
Table United States Neurological Biomarkers Sales by Application (2012-2017)
Table United States Neurological Biomarkers Sales Share by Application (2012-2017)
Figure United States Diagnostics Sales Growth (2012-2017)
Figure United States Drug Discovery Sales Growth (2012-2017)
Figure United States Personalized Medicine Sales Growth (2012-2017)
Figure United States Others Sales Growth (2012-2017)
Figure California Neurological Biomarkers Revenue and Growth (2012-2017)
Figure California Neurological Biomarkers Sales and Growth (2012-2017)
Table California Neurological Biomarkers Sales by Type (2012-2017)
Table California Neurological Biomarkers Sales Market Share by Type (2012-2017)
Table California Neurological Biomarkers Sales by Application (2012-2017)
Table California Neurological Biomarkers Sales Market Share by Application (2012-2017)
Figure New York Neurological Biomarkers Revenue and Growth (2012-2017)
Figure New York Neurological Biomarkers Sales and Growth (2012-2017)
Table New York Neurological Biomarkers Sales by Type (2012-2017)
Table New York Neurological Biomarkers Sales Market Share by Type (2012-2017)
Table New York Neurological Biomarkers Sales by Application (2012-2017)
Table New York Neurological Biomarkers Sales Market Share by Application (2012-2017)
Figure Texas Neurological Biomarkers Revenue and Growth (2012-2017)
Figure Texas Neurological Biomarkers Sales and Growth (2012-2017)
Table Texas Neurological Biomarkers Sales by Type (2012-2017)
Table Texas Neurological Biomarkers Sales Market Share by Type (2012-2017)
Table Texas Neurological Biomarkers Sales by Application (2012-2017)
Table Texas Neurological Biomarkers Sales Market Share by Application (2012-2017)
Figure Florida Neurological Biomarkers Revenue and Growth (2012-2017)
Figure Florida Neurological Biomarkers Sales and Growth (2012-2017)
Table Florida Neurological Biomarkers Sales by Type (2012-2017)
Table Florida Neurological Biomarkers Sales Market Share by Type (2012-2017)
Table Florida Neurological Biomarkers Sales by Application (2012-2017)
Table Florida Neurological Biomarkers Sales Market Share by Application (2012-2017)
Figure Illinois Neurological Biomarkers Revenue and Growth (2012-2017)
Figure Illinois Neurological Biomarkers Sales and Growth (2012-2017)
Table Illinois Neurological Biomarkers Sales by Type (2012-2017)
Table Illinois Neurological Biomarkers Sales Market Share by Type (2012-2017)
Table Illinois Neurological Biomarkers Sales by Application (2012-2017)
Table Illinois Neurological Biomarkers Sales Market Share by Application (2012-2017)
Figure United States Neurological Biomarkers Sales, Revenue and Growth Rate (2017-2022)
Table United States Neurological Biomarkers Sales Forecast by States (2017-2022)
Table United States Neurological Biomarkers Market Share Forecast by States (2017-2022)
Table United States Neurological Biomarkers Sales Forecast by Type (2017-2022)
Table United States Neurological Biomarkers Market Share Forecast by Type (2017-2022)
Table United States Neurological Biomarkers Sales Forecast by Application (2017-2022)
Table United States Neurological Biomarkers Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neurological Biomarkers
Figure Manufacturing Process Analysis of Neurological Biomarkers
Figure Neurological Biomarkers Industrial Chain Analysis
Table Raw Materials Sources of Neurological Biomarkers Major Manufacturers in 2016
Table Major Buyers of Neurological Biomarkers
Table Distributors/Traders/ Dealers List